Reason for request
Re-assessment of the Actual Benefit
Clinical Benefit
| Insufficient |
The actual benefit of the proprietary medicinal product ROHYPNOL is insufficient in the treatment of "severe sleep disorders in the following cases: occasional insomnia, transient insomnia". |
Therapeutic use
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
v4p3y8bG8r27eLhu
